• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-30
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hemorrhage, Cerebral (1889); High Blood Pressure/ Hypertension (1908); Confusion/ Disorientation (2553)
Event Date 08/13/2020
Event Type  Injury  
Manufacturer Narrative
Additional suspect medical device component involved in the event: product family: dbs-linear leads, upn: (b)(4), model: db-2202-30, serial: unknown, batch: unknown.
 
Event Description
It was reported that the patient experienced a stroke post implant of two leads for a trial period of the deep brain stimulation system.While in the recovery the patient developed confusion, high blood pressure.A scan was taken which confirmed the bleed in the area of the right thalamus.The patient was transferred back to the operating room at which time the external section of the leads, which were left externalized to connect to be connected at a later procedure, were cut to remove the external section and leaving the section of the leads implanted in the brain still implanted.The physician reported that he believes that the cause of the event was the initial insertion of the micro drive insertion cannula and before the lead was implanted.The patient is recovering and improving.The cut external sections of the leads were discarded by the facility and not returned for analysis.The serial number of the devices was not provided.
 
Event Description
It was reported that the patient experienced a stroke post implant of two leads for a trial period of the deep brain stimulation system.While in the recovery the patient developed confusion, high blood pressure.A scan was taken which confirmed the bleed in the area of the right thalamus.The patient was transferred back to the operating room at which time the external section of the leads, which were left externalized to connect to be connected at a later procedure, were cut to remove the external section and leaving the section of the leads implanted in the brain still implanted.The physician reported that he believes that the cause of the event was the initial insertion of the micro drive insertion cannula and before the lead was implanted.The patient is recovering and improving.The cut external sections of the leads were discarded by the facility and not returned for analysis.The serial number of the devices was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key10492385
MDR Text Key205671853
Report Number3006630150-2020-03923
Device Sequence Number1
Product Code NHL
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberDB-2202-30
Device Catalogue NumberDB-2202-30
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/17/2020
Initial Date FDA Received09/04/2020
Supplement Dates Manufacturer Received08/17/2020
Supplement Dates FDA Received09/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age85 YR
-
-